A Study of Nilotinib in Growing Vestibular Schwannomas
Status:
Terminated
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
Acoustic Neuromas (otherwise known as Vestibular Schwannoma -VS) are benign tumors which grow
on the hearing nerve and can cause progressive hearing loss and compression of vital brain
structures and even death if it continues. The primary objective of this study is to evaluate
the efficacy of Nilotinib in the treatment of patients with progressing VS. Secondary
objectives of this study is to evaluate the toxicity profile, quality of life and symptom
management of Nilotinib in the treatment of patients with progressing VS.